National Institutes of Health logo
NIH Exploratory/Developmental Grants Phase II (R33)

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research

Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.

OpenNational Institutes of HealthUnited States

A platform technology that could serve many different diagnostic or treatment purposes is a hard thing to fund through an ordinary disease-specific grant — it does not belong to one application. This notice is where NHLBI's Catalyze Program puts that kind of work.

The Catalyze Program overall exists to move basic science discoveries toward diagnostic and therapeutic candidates ready for human tes…

Rigorous validation of transformative, multi-use platforms or technologies with the potential to improve early detection and screening, model development, clinical diagnosis, treatment, control, behaviour, prevention or epidemiology for heart, lung, blood or sleep disease, under NHLBI's Catalyze Program.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.23 Dec 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.—
Funding pooliThe total budget available across all awards in this round.—

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 25 Aug 2026Funder reference: RFA-HL-26-016Source: www.grants.gov